Clinical Trial Detail

NCT ID NCT01361113
Title Neoadjuvant Pazopanib in Renal Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

renal cell carcinoma

Therapies

Pazopanib

Age Groups: senior adult

No variant requirements are available.